Article
Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1
2023-08-23
Abstract excerpt
<h4>Background: </h4> Due to the high drug resistance of hepatocellular carcinoma (HCC), Sorafenib has limited efficacy in the treatment of advanced HCC. Cancer-associated fibroblasts (CAFs) play an important regulatory role in the induction of chemo-resistance. This study aimed to clarify the mechanism underlying CAF-mediated resistance to sorafenib in HCC. <h4>Methods: </h4>: Immunohistochemistry and immunofluo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 88794111-073b-5f43-bbd6-750a99a40cd5
- DOI
- 10.21203/rs.3.rs-3152222/v1
